Global Transcatheter Aortic Valve Replacement/Implantation (TAVR/TAVI) Market Growth, Share, Size, Trends and Forecast (2025 - 2031)

By Procedure;

Transfemoral Implantation, Transapical Implantation, and Transaortic Implantation.

By Product Type;

Mechanical Heart Valves, Tissue Heart Valves, and Transcatheter Heart Valves.

By Application;

Hospitals, Cardiac Catheterization Laboratory, Ambulatory Surgical Centers (ASCs), and Others.

By Geography;

North America, Europe, Asia Pacific, Middle East and Africa and Latin America - Report Timeline (2021 - 2031).
Report ID: Rn465684497 Published Date: January, 2025 Updated Date: February, 2025

Introduction

Global Transcatheter Aortic Valve Replacement/Implantation (TAVR/TAVI) Market (USD Million), 2021 - 2031

In the year 2024, the Global Transcatheter Aortic Valve Replacement/Implantation (TAVR/TAVI) Market was valued at USD 7,382.81 million. The size of this market is expected to increase to USD 19,842.55 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 15.2%.

Transcatheter Aortic Valve Replacement/Implantation (TAVR/TAVI) has revolutionized the treatment of aortic valve stenosis, offering a less invasive alternative to traditional open-heart surgery. As the aging population grows and the prevalence of valvular heart diseases increases, the demand for TAVR/TAVI procedures has surged globally. This expansion is fueled by advancements in technology, such as improved valve designs, delivery systems, and imaging techniques, enhancing patient outcomes and expanding the pool of eligible candidates.

The global TAVR/TAVI market has witnessed remarkable growth, driven by factors like rising awareness among patients and physicians, coupled with favorable reimbursement policies in several countries. Moreover, the benefits of TAVR/TAVI, including shorter hospital stays, quicker recovery times, and reduced procedural risks compared to surgical options, have contributed to its widespread adoption. Additionally, ongoing clinical trials exploring the efficacy of TAVR/TAVI in low-risk patients are expected to further boost market growth by expanding the eligible patient population.

Geographically, North America and Europe have been at the forefront of TAVR/TAVI adoption, owing to well-established healthcare infrastructure, favorable reimbursement frameworks, and a high prevalence of aortic valve diseases. However, emerging economies in Asia-Pacific and Latin America are also witnessing rapid market growth, driven by increasing healthcare expenditure, improving access to advanced medical technologies, and a growing geriatric population. As technology continues to evolve and clinical evidence supporting TAVR/TAVI expands, the global market is poised for sustained growth in the coming years.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Procedure
    2. Market Snapshot, By Product Type
    3. Market Snapshot, By Application
    4. Market Snapshot, By Region
  4. Global Transcatheter Aortic Valve Replacement/Implantation (TAVR/TAVI) Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Aging Population
        2. Technological Advancements
        3. Rising Prevalence of Cardiovascular Diseases
        4. Increasing Demand for Minimally Invasive Procedures
      2. Restraints
        1. High Cost of Devices
        2. Regulatory Hurdles
        3. Lack of Skilled Professionals
        4. Limited Reimbursement Policies
      3. Opportunities
        1. Emerging Markets
        2. Development of Novel Devices
        3. Growing Awareness Programs
        4. Collaborations and Partnerships
    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Competitive Rivalry
  5. Market Segmentation
    1. Global Transcatheter Aortic Valve Replacement/Implantation (TAVR/TAVI) Market, By Procedure, 2021 - 2031 (USD Million)
      1. Transfemoral Implantation
      2. Transapical Implantation
      3. Transaortic Implantation
    2. Global Transcatheter Aortic Valve Replacement/Implantation (TAVR/TAVI) Market, By Product Type, 2021 - 2031 (USD Million)
      1. Mechanical Heart Valves
      2. Tissue Heart Valves
      3. Transcatheter Heart Valves
    3. Global Transcatheter Aortic Valve Replacement/Implantation (TAVR/TAVI) Market, By Application, 2021 - 2031 (USD Million)
      1. Hospitals
      2. Cardiac Catheterization Laboratory
      3. Ambulatory Surgical Centers (ASCs)
      4. Others
    4. Global Transcatheter Aortic Valve Replacement/Implantation (TAVR/TAVI) Market, By Geography, 2021 - 2031 (USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia & New Zealand
        5. South Korea
        6. ASEAN (Association of South East Asian Countries)
        7. Rest of Asia Pacific
      4. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
      5. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  6. Competitive Landscape
    1. Company Profiles
      1. Edwards Lifesciences Corporation
      2. Medtronic plc
      3. Abbott Laboratories
      4. Boston Scientific Corporation
      5. LivaNova PLC
      6. JenaValve Technology, Inc
      7. Meril Life Sciences Pvt. Ltd
      8. Bracco Imaging S.p.A
      9. CryoLife, Inc
      10. Transcatheter Technologies GmbH
  7. Analyst Views
  8. Future Outlook of the Market